Research map: Dasatinib Exposure and Risk of CMV Reactivation in Philadelphia Chromosome‐Positive Acute Lymphoblastic Leukemia

Back to the article

Papers in this map

  1. Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION) · Hagop M. Kantarjian · 2011 · 615 citations · Cited by this paper
  2. Systemic Mastocytosis in Adults: 2026 Update on Diagnosis, Risk Stratification and Management · 2026 · Related
  3. Dasatinib–Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults · Robin Foà · 2020 · 519 citations · Cited by this paper
  4. Treatment Patterns and Clinical Outcomes After Immunotherapy Failure in Patients With Natural Killer/T‐Cell Lymphoma · 2026 · Related
  5. Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study · Margaret L. Green · 2016 · 425 citations · Cited by this paper
  6. Intensive Induction in AML in the Era of Venetoclax: A Standing Count for “7 + 3”? · 2026 · Related
  7. Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy · Satu M. Mustjoki · 2009 · 327 citations · Cited by this paper
  8. ICC / WHO ‐Defined and NGS ‐Annotated Idiopathic Hypereosinophilia ( iHES / iHE ): Mutations, Clinical and Treatment Details, and Predictors of Survival · 2026 · Related
  9. Expansion of highly differentiated CD8+ T-cells or NK-cells in patients treated with dasatinib is associated with cytomegalovirus reactivation · Anna S. Kreutzman · 2011 · 101 citations · Cited by this paper
  10. Promoter TERT ‐ Related Hematopoietic Somatic Mosaicism in Patients With Telomere Biology Disorders · 2026 · Related
  11. Impact of Cytomegalovirus Viral Load on Probability of Spontaneous Clearance and Response to Preemptive Therapy in Allogeneic Stem Cell Transplantation Recipients · José F. Camargo · 2017 · 73 citations · Cited by this paper
  12. Mosaic Chromosomal Alterations Identify Ultra‐High Risk Clonal Hematopoiesis in Patients With Lymphoma Undergoing Intensive Chemotherapy · 2026 · Related
  13. Deep functional immunophenotyping predicts risk of cytomegalovirus reactivation after hematopoietic cell transplantation · José F. Camargo · 2018 · 56 citations · Cited by this paper
  14. A New Fetal Hemoglobin‐Related Phenotype in Sickle Cell Anemia · 2026 · Related
  15. Dasatinib-Induced Colitis after Allogeneic Stem Cell Transplantation for Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia · Ibrahim Taha Aldoss · 2016 · 55 citations · Cited by this paper
  16. p53 Immunohistochemistry Is a Reliable Method for Assessing TP53 Allelic and Functional Status in TP53 ‐Mutated Cases · 2026 · Related
  17. Incidence and outcomes of cytomegalovirus reactivation after chimeric antigen receptor T-cell therapy · Rick Y. Lin · 2024 · 43 citations · Cited by this paper
  18. Dexamethasone for Management of Cytokine Release Syndrome Associated With Talquetamab in Patients With Relapsed/Refractory Multiple Myeloma · 2026 · Related
  19. Immunomodulatory Effects of Tyrosine Kinase Inhibitor In Vitro and In Vivo Study · Elena Marinelli Busilacchi · 2017 · 38 citations · Cited by this paper
  20. Relapse Thresholds (12/24 Mo) Define Survival Disparity in Pediatric B‐ ALL · 2026 · Related
  21. Dasatinib Use and Risk of Cytomegalovirus Reactivation After Allogeneic Hematopoietic-Cell Transplantation · Daniel Paffili Prestes · 2017 · 31 citations · Cited by this paper
  22. Cytomegalovirus Colitis during Dasatinib Treatment for Patients with Hematologic Malignancy: Case Series and Literature Review · Jae-Ki Choi · 2018 · 22 citations · Cited by this paper
  23. Dasatinib-Induced CMV Hepatitis in an Immunocompetent Patient: A Rare Complication of a Common Drug · Fidencio Davalos · 2016 · 20 citations · Cited by this paper
  24. Dasatinib-induced colitis: clinical, endoscopic and histological findings · Kenji Yamauchi · 2022 · 15 citations · Cited by this paper
  25. How I treat adult Ph+ ALL · Sabina Chiaretti · 2024 · 13 citations · Cited by this paper
  26. Combining dasatinib with dexamethasone long-term leads to maintenance of antiviral and antileukemia specific cytotoxic T cell responses in vitro · Thomas Nerreter · 2013 · 7 citations · Cited by this paper
  27. Iron deficiency anemia: an early clinical presentation of cytomegalovirus-induced hemorrhagic colitis in chronic myeloid leukemia patients under dasatinib treatment · Laura Sánchez-Paz · 2024 · 3 citations · Cited by this paper
  28. Proven Cytomegalovirus Colitis Associated with Dasatinib Administration in Two Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients · Jeong Min Kim · 2023 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)